Streetbeat News

Stock Prices

BATRA

Liberty Braves Group (BATRA) reported a Q1 2024 GAAP EPS of $(0.83) and sales of $37.080M, missing the analyst consensus estimate of $40.500M by 8.44%. Despite the miss, this represents a 19.72% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:33 pm

NDAQ

Rosenblatt analyst Andrew Bond downgrades Nasdaq (NDAQ) from Buy to Neutral and lowers the price target from $76 to $64.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:31 pm

GLP

Global Partners (NYSE:GLP) reported a significant miss in Q1 earnings with EPS of $(0.37) against an estimate of $0.10, and sales of $4.14B against an estimate of $5.22B. This represents a 152.86% decrease in earnings and a 2.85% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:31 pm

SHLS

Shoals Technologies Group's shares dropped following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:31 pm

CLOV

Clover Health Investments' shares surged following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:30 pm

VSCO

Barclays analyst Adrienne Yih downgraded Victoria's Secret (NYSE:VSCO) from Equal-Weight to Underweight and reduced the price target from $15 to $14.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:28 pm

LL

LL Flooring Holdings, Inc (NYSE:LL) reported a significant decline in Q1 FY24 sales by 21.7% year-on-year to $188.49 million, missing analyst estimates. Comparable store sales dropped by 21.5%, and adjusted EPS showed a loss of $(1.04), also below expectations. Despite a gross margin increase, the company faced an expanded operating loss and cited challenging business conditions due to weaker home sales, high interest rates, and inflation. LL Flooring is not providing financial guidance due to macroeconomic uncertainties.

Portfolio Pulse from Shivani Kumaresan

May 08, 2024 | 12:27 pm

PRQR

ProQR Therapeutics NV (NASDAQ:PRQR) announced new preclinical data for its Axiomer RNA editing technology, including proof of concept for its AX-0810 program targeting NTCP for cholestatic diseases. The data, presented at the ASGCT Annual Meeting, shows meaningful changes in biomarkers in NHPs, marking a significant step towards clinical trials. A management webinar is scheduled for May 9, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:27 pm

LSXMK

Liberty SiriusXM Gr (LSXMK) reported Q1 sales of $2.14 billion, surpassing the analyst consensus estimate of $2.12 billion by 1.37%. The sales figure matches the performance from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:25 pm

FWONA

Liberty Formula One Group (NASDAQ:FWONA) reported Q1 earnings of $0.07 per share, surpassing the $0.04 estimate, marking a 112.07% increase from last year's losses. Sales reached $587M, beating the $582.69M estimate, a 54.07% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 08, 2024 | 12:25 pm